10 year assessment of infant hepatitis B vaccination program, in the Loyalty Islands (New Caledonia)

Alain Berlioz-Arthaud1, Philippe Perolat, Yves Buisson

  • 1Institut Pasteur de Nouvelle Calédonie, 12 rue Paul Doumer, BP 61, 98845 Nouméa Cedex, New Caledonia. aberloiz@pasteur.nc

Vaccine
|June 12, 2003
PubMed

Insights

Hepatitis B vaccination in New Caledonia shows good coverage but delayed primary doses impact prevalence reduction. A neonatal immunization program with preadolescent catch-up boosters is recommended for hepatitis B eradication.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Vaccinology

Background:

  • Hepatitis B poses a significant global health challenge.
  • Neonatal vaccination programs are crucial for controlling hepatitis B transmission.

Purpose of the Study:

  • To assess the impact of a 10-year neonatal hepatitis B vaccination program in New Caledonia.
  • To determine the necessity of booster doses for preadolescents.

Main Methods:

  • A serological survey was conducted among 593 children aged 8-11 years in the Loyalty Islands.
  • Analysis included antibodies to core and surface antigens and HBsAg detection.

Main Results:

  • Vaccine coverage reached 93%, with 89% of children protected against hepatitis B.
  • Despite high coverage, 8% had prior viral contact and 1.3% were carriers.
  • 38% received their initial vaccination after 3 months of age, indicating delays.

Conclusions:

  • Neonatal immunization is accepted and followed in New Caledonia.
  • Delayed primary vaccination likely limited the expected reduction in hepatitis B prevalence.
  • Hepatitis B eradication may be achievable with timely birth-dose vaccination and a comprehensive preadolescent catch-up program.
Abstract